We report the proportion of patients treated with cardiovascular prophylactic medications in the Usual Care control arm at baseline, Months 4, and 12.Design and Method: Eligible patients were aged between 35 and 79 years with treated or untreated hypertension and 3þ additional risk factors, but no history of coronary disease and baseline total cholesterol 6.5 mmol/L or less and not receiving a statin. Patients received 12 months' treatment with single-pill amlodipine/atorvastatin-based treatment or continued usual care.

No abstract

No abstract

No abstract

No abstract